What We're Reading: Page 308
Industry reads hand-picked by our editors
Feb 24, 2017
-
Bloomberg
Sworn to secrecy, drugstores stay silent as customers overpay
-
Reuters
Advent raises bid in three-way tussle for Stada
-
The Washington Post
Rise in mumps outbreaks prompts U.S. officials to weigh third vaccine dose
-
Forbes
This company with anti-aging drug is secretly preparing for Trump's new FDA
Feb 23, 2017
-
MIT Technology Review
How did gene therapy go from experimental disasters to wondrous cures?
-
ProPublica
Big pharma quietly enlists leading professors to justify $1,000-per-day drugs
-
Bloomberg
China widens drug insurance coverage, boosting pharma stocks
-
Medical Marketing & Media
Why pharma refuses to see value in 'influence'
-
Harvard Business Review
The Edison of medicine
Feb 22, 2017
-
Boston Business Journal
Top pharma lobbyist casts Biogen as the anti-Shkreli during drug price Q&A
-
USA Today
New patient group focuses on drug prices amid bipartisan concern
-
The Hill
Hopes rise for law to expand access to experimental drugs
-
The Atlantic
Is the leading theory about Alzheimer's wrong?
Feb 21, 2017
-
BBC
How drug development is speeding up in the cloud
-
Financial Times
Big pharma bets billions on ‘silent’ liver disease
-
Reuters
Company-funded studies of approved drugs may not catch safety issues
-
Kaiser Health News
Facing pressure, insurance plans loosen rules for covering addiction treatment
-
The Wall Street Journal
Alzheimer’s: pharma’s great white whale is still worth hunting
Feb 17, 2017
-
The Wall Street Journal
FBI searches for possible accomplices in probe of fallen K Street lobbyist
-
Regulatory Focus
House bill seeks to add mandatory drug recall authority to FDA’s arsenal
-
Los Angeles Times
Big pharma really, really doesn't want you to know the true value of its drugs
-
Business Insider
We dug into the drug company Martin Shkreli sold out to the feds, and man is it ugly
-
The Atlantic
The flawed designs of drug trials for autism
Feb 16, 2017
-
Fortune
Why drug companies don’t want President Trump to deregulate the FDA
-
Politico
Humana becomes first major insurer to quit Obamacare exchanges
-
The Baltimore Sun
Health care advocates make pitch for bills to block drug price hikes
-
Bloomberg
Drugmakers boost Indian shares as Sun Pharma snaps losing streak
Feb 15, 2017
-
Reuters
Pharma industry shuns Trump push for radical shift at FDA
-
Healthcare Dive
Aetna, Humana drop merger plans
-
Axios
Uninsured rate is down, but deductibles are up
-
Charleston Gazette-Mail
WV town sues drug firm ‘sharks’ over opioids
-
MIT Technology Review
U.S. panel endorses designer babies to avoid serious disease
Previous
